Abstract:BackgroundCardiac Implantable Electronic Devices (CIEDs) are widely used for the management of advanced heart failure and ventricular arrhythmias. CIED‐Infection (CIED‐I) has very high mortality, especially in the subsets of patients with limited health‐care access and delayed presentation. The purpose of this study is to identify the risk‐predictors mortality in subjects with CIED‐I.MethodsWe performed a retrospective cohort study of a regional database in patients presenting with CIED infections to tertiary care medical centers across Western New York, USA from 2012 – 2020. The clinical outcomes included recurrent device infection (any admission for CIED‐I after the first hospitalization for device infection), septic complications (pulmonary embolism, respiratory failure, septic shock, decompensated HF, acute kidney injury) and mortality outcomes (death during hospitalization, within 30 days from CIED‐I, and within 1 year from CIED‐I). We studied associations between categorical variables and hard outcomes using chi‐square tests and used one‐way analysis of variance to measure between‐groups differences.ResultsWe identified 296 patients with CIED‐I, among which 218 (74%) were male, 237 (80%) were white and the mean age at the time of infection was 69.2±13.7 years. One‐third of the patients were referred from the regional facilities. Staphylococcus aureus was responsible for most infections, followed by Enterococcus fecalis. On multivariate analysis, the covariates associated with significantly increased mortality risk included referral from regional facility (OR: 2.0;1.0‐4.0), hypertension (Odds ratio, OR: 3.2;1.3‐8.8), right ventricular dysfunction (OR: 2.6;1.2‐5.1), end‐stage renal disease (OR: 2.6;1.1‐6.2), immunosuppression (OR: 11.4;2.5‐53.3), and septic shock as a complication of CIED‐I (OR: 3.9;1.3‐10.8).ConclusionHypertension, right ventricular dysfunction, immunosuppression, and end‐stage renal disease are associated with higher mortality after CIED‐I. Disproportionately higher mortality was also noted in subjects referred from the regional facilities. This underscores the importance of early clinical risk‐assessment, and the need for a robust referral infrastructure to improve patient outcomes.This article is protected by copyright. All rights reserved.

Prevention and Risk Assessment of Cardiac Device Infections in Clinical Practice

Antibiotic Prophylaxis and Treatment for Cardiac Device Infections

Tailored Care for Cardiac Health: Risk Stratification and Gentamicin-Infused Collagen Sponges to Minimize Cardiac Device Infections and Healthcare Costs

New advances in management and treatment of cardiac implantable electronic devices infections

Prevention and Management of Cardiac Implantable Electronic Device Infections: State-of-the-Art and Future Directions

Burden of disease and costs of infections associated with cardiac implantable electronic devices

Measures to Prevent Infection in Cardiac Implantable Electronic Device Replacements or Upgrades

An Approach to Cardiac Implantable Electronic Device Pocket Infections: From Prevention to Diagnosis and Management

Cardiovascular Implantable Electronic Device Infections: A Contemporary Review

Incidence and Predictors of Infections and All-Cause Death in Patients with Cardiac Implantable Electronic Devices: The Italian Nationwide RI-AIAC Registry

Evidence-Based Strategies to Promote Long-Term Cardiac Implant Site Health: Review of the Literature

Cardiac implantable electronic devices and bloodstream infections: management and outcomes

Cardiac device infections: getting to the heart of the matter

Trends of Cardiovascular Implantable Electronic Device Infection in 3 Decades A Population-Based Study

Infective Endocarditis Involving Implanted Cardiac Electronic Devices: JACC Focus Seminar 1/4

Cardiovascular Implantable Electronic Device Infection and New Insights About Correlation Between Pro-inflammatory Markers and Heart Failure: A Systematic Literature Review and Meta-Analysis

Trends in Managing Cardiac and Orthopaedic Device-Associated Infections by Using Therapeutic Biomaterials

Mortality and Costs of Cardiac Implantable Electronic Device (CIED) Infections According to the Therapeutic Approach: A Single-Center Cohort Study

Cardiovascular implantable electronic device infections due to enterococcal species: Clinical features, management, and outcomes

Contemporary Management of Cardiac Implantable Electronic Device Infection: The American College of Cardiology COGNITO Survey

Risk Factors Associated with Higher Mortality in Patients with Cardiac Implantable Electronic Device Infection